RAP 0.00% 20.5¢ resapp health limited

Ann: Results from Data Confirmation Study, page-10

  1. 1,428 Posts.
    lightbulb Created with Sketch. 455
    If I was a shareholder, I'd be feeling pretty lucky that Pfizer have locked in 14.5c takeover offer.

    Thise results are very mediocre, and use case with regard to Covid is dwindling.

    Seems like Pfizer got a poor deal, but great for RAP shareholders.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.